Clinical Trials
2 trialsNCT04968002 2021-07-20
Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown
NCT02780778 2016-05-23
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown